EYPT
EyePointANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
EYPT vs peer average
95/100
EYPT vs. peer average (A vs. D)
Grade spread
C 1 · D 3 · F 6
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
KOD is the first available peer comparator.
Kodiak Sciences is a retinal-disease clinical comparator with wet-AMD and DME development programs. Different drugs, designs and timelines make it an imperfect pricing peer. [Kodiak company release](https://ir.kodiak.com/news-releases/news-release-details/kodiak-sciences-announces-recent-business-highlights-and-3)
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EYPT
EyePoint
KOD
Kodiak Sciences
Grade
A
F
Momentum
1
100
Value
58
41
Sentiment
79
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs KOD
EYPT / KOD
Grade Position
Above peers
EYPT vs. peer average (A vs. D)
95/100
Momentum
1
KODValue
58
EYPTSentiment
79
EYPTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EYPT
KOD is the first peer returned for this comparison set.